Acute myeloid leukemia (non-M3)
Conditions
Interventions
Case series:NA
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 74 Years
Inclusion criteria
Inclusion criteria: (1) Patients with primary AML diagnosed according to the WHO classification criteria for tumors of hematopoietic and lymphoid tissues and treated with at least 1 course of treatment with Vinaclat in combination with the 3+7 regimen. (2) Age 18-74 years old and gender; (3) Eastern Cooperative Oncology Group (ECOG) score 0-3; (4) Patients understood and voluntarily participated in this study by signing an informed consent form.
Exclusion criteria
Exclusion criteria: (1) women who were pregnant, preparing for pregnancy, or breastfeeding; (2) with other tumors; (3) with severe organ insufficiency and an expected survival of less than 1 year; and (4) patients in whom other induction chemotherapy regimens were used during the course of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall response rate, ORR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival, PFS;Overall survival, OS; | — |
Countries
China
Contacts
Public ContactLi Hui
Department of Hematology, Sichuan Provincial People's Hospital
Outcome results
None listed